BINDER acquires Parameter Generation & Control
Advertisement
BINDER is pleased to announce the acquisition of Parameter Generation & Control, a U.S.-based manufacturer specializing in Walk-In humidity and temperature control systems.
This strategic acquisition enhances BINDER’s product portfolio and strengthens the company’s position in delivering best-in-class solutions for environmental simulation technology.
Expanded Solutions Across Key Industries
With Parameter’s expertise, BINDER now offers an even broader range of humidity and temperature control solutions tailored to meet the stringent requirements of various industries:
- Pharmaceuticals and Biotechnology: Stability testing and precise environmental control for critical research and production.
- Cosmetics: Humidity and temperature control for product stability and testing.
- Food and Beverages: Quality and shelf-life testing under controlled conditions.
- Automotive & Aerospace: Environmental simulation for component testing and material performance.
- Electronics: Precision conditioning of electronic components for reliability and compliance.
- Additional Industries: Materials testing, packaging, and more.
Commitment to Innovation and Excellence
This acquisition supports BINDER’s long-term vision to expand product offerings and enhance service capabilities. By integrating Parameter’s advanced technology and industry-specific solutions, BINDER is perfectly equipped to meet the evolving needs of customers worldwide—delivering advanced technologies, pioneering innovations, and absolute precision in environmental simulation technology.
The company is excited about the opportunities this partnership brings and remains dedicated to delivering exceptional value and solutions to its global customers.
Most read news
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Sanofi to acquire biotech start-up Vicebio - Expanding respiratory vaccines pipeline

Where science powers start-ups - New biotech hub BioLabs|TUM launched to foster start-ups

Labguru and Titian Software Rebrand as Cenevo - Cenevo brings together lab management systems Labguru and Mosaic to unlock the full potential of labs and accelerate scientific discovery

€12M for LIfT BioSciences: Breakthrough in Cancer Therapy? - The grant from Ireland's Disruptive Technologies Innovation Fund will support the first-in-human clinical trial of LIfT's IMAN therapy

Bayer posts positive second quarter and progress on strategic priorities

Merck Delivers Profitable Organic Growth Amid Strong Currency Headwinds - Strong sales in Process Solutions and for blockbusters Mavenclad and Erbitux, sustained demand for Semiconductor Materials

Head-to-head against AI, pharmacy students won - A study showed that when compared with students, ChatGPT 3.5 was less likely to correctly answer questions on therapeutics exams focused on clinical applications and cases.

How immune cells switch into attack mode - New insights into macrophage biology

Researchers discover previously unknown "mini-factories" for protein folding

Study finds caffeine can weaken effectiveness of certain antibiotics - Researchers discover substances bacteria can find in their natural environment trigger their alert systems

Ready-made pizza & co.: How fast food damages the brain - Ultra-highly processed is ultra-poor
